BrainZell

BrainZell is a company that pioneers the future of compound testing by replacing and reducing traditional animal testing with cutting-edge human cell models. They aim to shape a more sustainable future for medicine. BrainZell offers services for early drug testing, toxicity assessment, and safety profiling, empowering their clients to make informed decisions about the safety and efficacy of compounds. Their human cell models faithfully mimic the structure and function of the human brain, and they are capable of large-scale and high-throughput testing, providing several data points in a single run. BrainZell uses human induced pluripotent stem cells (hiPSCs) to create organoids that resemble the architecture and functionality of the human brain. Their innovative technology for producing cortical organoids on a very large scale is patent-pending and forms the core of BrainZell's technology. The company ensures a seamless experience for their clients from project initiation to the delivery of valuable insights, and they are committed to accelerating the development of life-changing therapies by unlocking the mysteries of the human brain.